Taking Tally Of Infosys Limited (INFY), Achaogen, Inc. (AKAO)

The shares of Infosys Limited have increased by more than 2.47% this year alone. The shares recently went down by -7.72% or -$1.39 and now trades at $16.62. The shares of Achaogen, Inc. (NASDAQ:AKAO), has jumped by 15.36% year to date as of 04/13/2018. The shares currently trade at $12.39 and have been able to report a change of 1.98% over the past one week.

The stock of Infosys Limited and Achaogen, Inc. were two of the most active stocks on Friday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. The ROI of INFY is 16.40% while that of AKAO is -82.00%. These figures suggest that INFY ventures generate a higher ROI than that of AKAO.

Cash Flow

The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, INFY’s free cash flow per share is a positive 50.21, while that of AKAO is negative -0.32.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for INFY is 3.70 and that of AKAO is 4.80. This implies that it is easier for INFY to cover its immediate obligations over the next 12 months than AKAO. The debt ratio of INFY is 0.00 compared to 0.26 for AKAO. AKAO can be able to settle its long-term debts and thus is a lower financial risk than INFY.


INFY currently trades at a forward P/E of 14.64, a P/B of 3.41, and a P/S of 3.63 while AKAO trades at a P/B of 4.32, and a P/S of 46.81. This means that looking at the earnings, book values and sales basis, INFY is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of INFY is currently at a -1.25% to its one-year price target of 16.83. Looking at its rival pricing, AKAO is at a -42.53% relative to its price target of 21.56.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), INFY is given a 2.90 while 1.80 placed for AKAO. This means that analysts are more bullish on the outlook for INFY stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for INFY is 14.55 while that of AKAO is just 10.03. This means that analysts are more bullish on the forecast for AKAO stock.


The stock of Achaogen, Inc. defeats that of Infosys Limited when the two are compared, with AKAO taking 5 out of the total factors that were been considered. AKAO happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, AKAO is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for AKAO is better on when it is viewed on short interest.

Previous ArticleNext Article

Related Post

Uncovering the next great stocks: ForeScout Techno... The shares of ForeScout Technologies, Inc. have decreased by more than -6.18% this year alone. The shares recently went down by -2.06% or -$0.63 and n...
Which is more compelling pick right now? – S... The shares of Sorrento Therapeutics, Inc. have increased by more than 85.53% this year alone. The shares recently went up by 3.68% or $0.25 and now tr...
Which is more compelling pick right now? – C... The shares of CenturyLink, Inc. have increased by more than 7.01% this year alone. The shares recently went up by 1.13% or $0.2 and now trades at $17....
Checking Out the Fundamental Data for DelMar Pharm... DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) is an interesting stock at present. Now trading with a market value of 13.95M, the company has a mix of cat...
Forum Energy Technologies, Inc. (FET): Interesting... Forum Energy Technologies, Inc. (NYSE:FET) is one of the active stocks and its unusual movement is raising eyebrows among traders. Now trading with a ...